多病共存与镇痛药相关伤害:一项系统综述
多数阿片类研究(12/16)报告不良结局,阿片使用与非使用相比与死亡率增加相关;多病共存与阿片过量及死亡相关。NSAIDs研究半数(6/11)报告不良结局包括消化道出血;仅1项研究评估加巴喷丁类,发现与谵妄和肺炎相关但与死亡率无关。
要点
- 多病共存成人使用阿片类与死亡率增加相关,且多病共存与阿片过量及死亡相关。
- NSAIDs研究半数报告不良结局,包括消化道出血。
- 加巴喷丁类证据缺乏,仅1项研究报告谵妄和肺炎关联。
核心结论
- 有证据表明多病共存成人使用阿片类存在伤害,包括过量与死亡率增加。
- 加巴喷丁类证据缺乏,需进一步研究多病共存者的最佳镇痛管理。
研究设计与样本
- 系统综述,注册于PROSPERO(CRD42023462592)。
- 两名研究者独立筛选、提取数据并使用Newcastle-Ottawa量表评估偏倚风险,采用叙事综合按镇痛药类别和效应方向分组。
主要发现
- 多数阿片类研究(12/16)报告不良结局;阿片使用与非使用相比与多病共存成人死亡率增加相关。
- 多病共存与因疼痛处方阿片类的成人中阿片过量及死亡相关。
- NSAIDs研究半数(6/11)报告不良结局,包括消化道出血。
- 仅1项研究评估加巴喷丁类,发现与谵妄和肺炎相关,但与死亡率无关。
临床怎么用
- 多病共存成人处方阿片类时需警惕过量与死亡风险。
- NSAIDs需关注消化道出血等不良结局。
- 加巴喷丁类在多病共存者中的安全性证据不足。
局限性
- 研究异质性大,质量参差,11项研究高偏倚风险。
- 加巴喷丁类仅1项研究评估,证据缺乏。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Multimorbidity is the presence of two or more long-term medical conditions. Chronic pain affects more than half of people with multimorbidity, and optimal treatment strategies are unknown. We aimed to quantify the risk of adverse outcomes from the following analgesics: opioids, nonsteroidal anti-inflammatory drugs (NSAIDs), and gabapentinoids in adults with multimorbidity. METHOD: The review was registered on PROSPERO (CRD42023462592). We searched Medline, CINAHL, Web of Science, Embase, and CENTRAL for studies reporting analgesic-related harms in people with multimorbidity or the impact of multimorbidity on harms in adults exposed to analgesics. Two researchers independently screened titles/abstracts, completed full-text reviews, extracted data, and assessed risk of bias using the Newcastle-Ottawa scale. Studies were synthesised narratively, grouping by analgesic class and direction of effect. RESULTS: We screened 6690 records and 344 full texts, with 27 studies included (n=2 671 958 patients). Studies were heterogenous, with variable quality (high risk of bias, n=11). Most studies on opioids reported adverse outcomes (12/16). Opioid use compared with non-use was associated with increased mortality in adults with multimorbidity. Multimorbidity was associated with opioid overdose and death among adults prescribed opioids for pain. Half of studies of NSAIDs reported adverse outcomes (6/11) including gastrointestinal bleeding. Only one study assessed gabapentinoids which found an association with delirium and pneumonia, but not mortality in people with multimorbidity. CONCLUSIONS: There is evidence of harms associated with opioids in adults with multimorbidity, including overdose and increased mortality. There is a lack of evidence on gabapentinoids. Further research is required to understand optimal analgesic management in people with multimorbidity. SYSTEMATIC REVIEW PROTOCOL: PROSPERO (CRD42023462592).
引用
- Grant CH, Walker H, Barnett KN, et al. Multimorbidity and analgesic-related harms: a systematic review. Br J Anaesth. 2025. PMID: 40113476. doi:10.1016/j.bja.2025.02.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。